These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22045486

  • 1. Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice.
    Lee S, Lemere CA, Frost JL, Shea TB.
    J Alzheimers Dis; 2012; 28(2):423-31. PubMed ID: 22045486
    [Abstract] [Full Text] [Related]

  • 2. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 3. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 4. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.
    Neuroscience; 2009 Mar 03; 159(1):296-307. PubMed ID: 19135506
    [Abstract] [Full Text] [Related]

  • 5. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM.
    J Neurochem; 2007 Aug 03; 102(4):1053-63. PubMed ID: 17472708
    [Abstract] [Full Text] [Related]

  • 6. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
    Baglietto-Vargas D, Moreno-Gonzalez I, Sanchez-Varo R, Jimenez S, Trujillo-Estrada L, Sanchez-Mejias E, Torres M, Romero-Acebal M, Ruano D, Vizuete M, Vitorica J, Gutierrez A.
    J Alzheimers Dis; 2010 Aug 03; 21(1):119-32. PubMed ID: 20413859
    [Abstract] [Full Text] [Related]

  • 7. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 8. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
    Baazaoui N, Iqbal K.
    J Alzheimers Dis; 2017 Sep 23; 58(1):215-230. PubMed ID: 28387677
    [Abstract] [Full Text] [Related]

  • 9. Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.
    Soejima N, Ohyagi Y, Nakamura N, Himeno E, Iinuma KM, Sakae N, Yamasaki R, Tabira T, Murakami K, Irie K, Kinoshita N, LaFerla FM, Kiyohara Y, Iwaki T, Kira J.
    Curr Alzheimer Res; 2013 Jan 23; 10(1):11-20. PubMed ID: 22950910
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J, Lauretti E, Craige CP, Praticò D.
    J Alzheimers Dis; 2014 Jan 23; 41(3):729-37. PubMed ID: 24662099
    [Abstract] [Full Text] [Related]

  • 11. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A, Sprenger F, Bayer TA, Wirths O.
    Neurobiol Aging; 2013 Nov 23; 34(11):2564-73. PubMed ID: 23747045
    [Abstract] [Full Text] [Related]

  • 12. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K.
    Neurobiol Dis; 2014 Nov 23; 71():110-30. PubMed ID: 25046994
    [Abstract] [Full Text] [Related]

  • 13. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
    Lopes JP, Blurton-Jones M, Yamasaki TR, Agostinho P, LaFerla FM.
    J Alzheimers Dis; 2009 Nov 23; 16(3):541-9. PubMed ID: 19276549
    [Abstract] [Full Text] [Related]

  • 14. Tau transgenic mice as models for cerebrospinal fluid tau biomarkers.
    Barten DM, Cadelina GW, Hoque N, DeCarr LB, Guss VL, Yang L, Sankaranarayanan S, Wes PD, Flynn ME, Meredith JE, Ahlijanian MK, Albright CF.
    J Alzheimers Dis; 2011 Nov 23; 24 Suppl 2():127-41. PubMed ID: 21422517
    [Abstract] [Full Text] [Related]

  • 15. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E, Shoji M, Kawarabayashi T, Sasaki A, Matsubara E, Murakami T, Wuhua X, Tamura S, Ikeda M, Ishiguro K, Saido TC, Westaway D, St George Hyslop P, Harigaya Y, Abe K.
    Brain Res; 2006 Jun 13; 1094(1):192-9. PubMed ID: 16713590
    [Abstract] [Full Text] [Related]

  • 16. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L.
    Neurobiol Dis; 2010 Feb 13; 37(2):294-306. PubMed ID: 19781645
    [Abstract] [Full Text] [Related]

  • 17. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW, Ogino K, Shimabuku A, Taki T, Nakashima H, Ishihara T, Kitamoto T.
    Acta Neuropathol; 2007 Jun 13; 113(6):627-36. PubMed ID: 17431643
    [Abstract] [Full Text] [Related]

  • 18. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice.
    Minami SS, Clifford TG, Hoe HS, Matsuoka Y, Rebeck GW.
    Neurobiol Aging; 2012 Apr 13; 33(4):825.e15-24. PubMed ID: 21741124
    [Abstract] [Full Text] [Related]

  • 19. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP, Giardino L, Sivilia S, Giuliani A, Gusciglio M, Pietrini V, Del Giudice E, D'Arrigo A, Leon A, Villetti G, Calzà L.
    J Alzheimers Dis; 2010 Apr 13; 20(1):159-73. PubMed ID: 20164581
    [Abstract] [Full Text] [Related]

  • 20. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
    Kapadia M, Mian MF, Michalski B, Azam AB, Ma D, Salwierz P, Christopher A, Rosa E, Zovkic IB, Forsythe P, Fahnestock M, Sakic B.
    J Alzheimers Dis; 2018 Apr 13; 63(3):1191-1205. PubMed ID: 29710702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.